While supplies of the updated Pfizer booster shot appear to be plentiful, some pharmacies have reported not having enough Moderna vaccine
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Sept. 22, 2022 (HealthDay News) -- To keep up with demand for updated booster shots, U.S. health officials are shipping out more batches of the revamped Moderna vaccine to pharmacies across the country.
While supplies of the updated Pfizer booster shot appear to be plentiful, some pharmacies have reported not having enough Moderna vaccine, CNN reported. Walgreens said its Moderna booster supply was limited, causing appointments to vary. It had Pfizer doses.
"We have received limited supply of the Moderna COVID-19 booster and expect to receive additional supply in the coming weeks. We are actively working to increase inventory of COVID boosters and have sufficient supply of Pfizer updated boosters in all stores," Rite Aid said earlier this week, CNN reported.
Both of the new boosters were authorized by the U.S. Food and Drug Administration earlier this month. However, at that time, the FDA was inspecting one facility where the Moderna vaccine is made and "did not include this facility as an authorized manufacturing facility for the updated COVID-19 vaccine booster at that time," FDA spokesman Michael Felberbaum told CNN. As a result, only COVID-19 vaccine shots from another Moderna facility were shipped out.
More supplies will now be made available "following a careful review of information provided by Moderna about the manufacture of these batches. The agency has no concerns with the safety, effectiveness, or quality of these batches," Felberbaum said.
Despite the current shortage, Moderna said it still plans to deliver 70 million doses of its new vaccine by the end of this year. "We are working closely with [the] U.S. Government to deliver significant amounts of updated, bivalent booster doses as we continue to see high demand in certain areas of the country," the company told CNN. "We anticipate that these availability constraints will be resolved in the coming days."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Published on September 22, 2022
Read this Next
Other Trending Articles